2377. Outcomes in Patients With History of Cardiac or Vascular Disease (CV) During Treatment of Acute Bacterial Skin And Skin Structure Infection (ABSSSI) With Delafloxacin (DLX) vs. Vancomycin/Aztreonam (VAN/AZ)

BACKGROUND: DLX, an anionic fluoroquinolone antibiotic with Gram-positive and Gram-negative activity, was recently approved for treatment of ABSSSI. Two global phase 3 ABSSSI trials (studies 302 and 303) included patients with cardiac or vascular disease. METHODS: Two multicenter, double-blind, doub...

Descripción completa

Detalles Bibliográficos
Autores principales: Oguchi, Godson, Beasley, Richard, Lawrence, Laura, Tseng, Carol, Cammarata, Sue K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254169/
http://dx.doi.org/10.1093/ofid/ofy210.2030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254169/
http://dx.doi.org/10.1093/ofid/ofy210.2030

Ejemplares similares